Article
Differential Activity of Repurposed Drugs as Receptor Binding Domain Antagonists for <i>Omicron</i> and Native Strains of SarsCov2
2022-03-09
Abstract excerpt
Omicron strain is the latest variant of concern of SarsCov2 virus. The mutations in this strain in the S protein Receptor Binding domain (RBD) enable it to be more transmissible as well as escape neutralizing activity by antibodies in response to vaccine. Thus, Omicron specific strategies are need to counter infection by this strain. We investigated a collection of approved drugs shown to antagonize the binding of...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 43c5aa1d-243c-5dd0-bd6b-a205ecdc8961
- DOI
- 10.1101/2022.03.09.483630
